Syra Health Corp. Class A Common Stock (SYRA) Earnings History
Annual and quarterly earnings data from 2020 to 2024
Loading earnings history...
EPS Growth Rates (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 20.7% | -47.2% | -47.1% |
| 2023 | 25.5% | -52.4% | -53.3% |
| 2022 | 18.9% | -37.2% | -37.7% |
| 2021 | 30.5% | -0.2% | -0.2% |
| 2020 | - | - | - |
Download Data
Export SYRA earnings history in CSV or JSON format
Free sign-in required to download data
Syra Health Corp. Class A Common Stock (SYRA) Earnings Overview
As of February 28, 2026, Syra Health Corp. Class A Common Stock (SYRA) reported trailing twelve-month net income of -$1M, reflecting +0.1% year-over-year growth. The company earned $-0.11 per diluted share over the past four quarters, with a net profit margin of -0.5%.
Looking at the long-term picture, SYRA's historical earnings data spans multiple years. The company achieved its highest annual net income of -$3,280 in fiscal 2021.
Syra Health Corp. Class A Common Stock is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to industry peers including SOLV ($1.56B net income, 0.2% margin), HCSG ($40M net income, 0.0% margin), AMN (-$96M net income, -0.0% margin), SYRA has room to improve margins relative to the peer group. Compare SYRA vs SOLV →
Peer Comparison
Earnings metrics vs industry competitors
Historical Data
5 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$4M | -27.9% | -$4M | $-0.52 | -47.1% | -47.2% |
| 2023 | -$3M | -38.7% | -$3M | $-0.60 | -53.3% | -52.4% |
| 2022 | -$2M | -64478.2% | -$2M | $-0.29 | -37.7% | -37.2% |
| 2021 | $-3,280 | +23.1% | $-3,280 | $-0.00 | -0.2% | -0.2% |
| 2020 | $-4,267 | - | $-4,267 | $-0.00 | - | - |
See SYRA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SYRA Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare SYRA vs AGIO
See how SYRA stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is SYRA growing earnings?
SYRA EPS of $-0.11 reflects slowing growth at +0.1%, below the 5-year CAGR of N/A. TTM net income is $-1M. Expansion rate has moderated.
What are SYRA's profit margins?
Syra Health Corp. Class A Common Stock net margin is -0.5%, with operating margin at -0.5%. Below-average margins reflect competitive or cost pressures.
How consistent are SYRA's earnings?
SYRA earnings data spans 2020-2024. The current earnings trend is +0.1% YoY. Historical data enables comparison across business cycles.